1. Home
  2. SPHL vs ENVB Comparison

SPHL vs ENVB Comparison

Compare SPHL & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Springview Holdings Ltd Class A Ordinary Shares

SPHL

Springview Holdings Ltd Class A Ordinary Shares

BUY

Current Price

$2.33

Market Cap

7.1M

ML Signal

BUY

Logo Enveric Biosciences Inc.

ENVB

Enveric Biosciences Inc.

SELL

Current Price

$1.43

Market Cap

6.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SPHL
ENVB
Founded
2002
1994
Country
Singapore
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
6.7M
IPO Year
2023
2000

Fundamental Metrics

Financial Performance
Metric
SPHL
ENVB
Price
$2.33
$1.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 192.4K
73.6K
Earning Date
10-28-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $39,914,675.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.36
$1.17
52 Week High
$25.11
$795.00

Technical Indicators

Market Signals
Indicator
SPHL
ENVB
Relative Strength Index (RSI) 47.46 41.95
Support Level $2.22 $1.17
Resistance Level $2.66 $1.53
Average True Range (ATR) 0.18 0.09
MACD -0.00 -0.01
Stochastic Oscillator 47.14 34.84

Price Performance

Historical Comparison
SPHL
ENVB

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd conducts its operations through its indirect wholly-owned subsidiary, which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of work, including new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment in the development of construction projects. It derives maximum revenue from its Residential Customers.

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Share on Social Networks: